functional dyspepsia

Acotiamide monohydrochloride trihydrate (Z-338 HCl) 是一种首创的、具有口服活性的胃肠动力药。它通过促毒蕈碱受体拮抗作用和乙酰胆碱酯酶(AChE)抑制作用增强肠神经元释放的乙酰胆碱，从而增强胃排空和胃部适应性，有潜力用于功能性消化不良的研究。

Itopride HCl is an AChE inhibitor and dopamine D2 receptor antagonist. It inhibits lower esophageal sphincter relaxation. It also used to treat functional dyspepsia and gastroesophageal reflux disease

R-137696为一种口服活性的5-HT1A受体激动剂，其主要作用为放松近端胃部，适用于研究功能性消化不良。

TD-2749是Theravance通过多价化合物设计在旨在寻找治疗胃肠动力障碍新化合物的化合物发现项目中发现的选择性5-HT4激动剂。该化合物主要用于治疗慢性便秘、便秘型肠易激综合征(C-IBS)、阿片类化合物引起的便秘、功能性消化不良和糖尿病性胃轻瘫等疾病。

Acotiamide 是一种具有口服活性、选择性和可逆性的乙酰胆酶碱酯 (AChE) 抑制剂，IC50值为1.79 μM。Acotiamide 是一种胃促动力剂，可增强胃收缩性并加速胃排空延迟。Acotiamide 可用于胃动力障碍的功能性消化不良及肠道炎症的研究。

Acotiamide hydrochloride 是选择性的、口服具有活力的、可逆的乙酰胆酶碱酯 (AChE) 抑制剂 (IC50: 1.79 μM)，能够提高胃收缩性，加速胃排空延迟，能够用于研究胃动力障碍的功能性消化不良及肠道炎症。

Bromopride hydrochloride is the salt form of Bromopride, a dopamine D2 receptor blocker. Bromopride exerts is a gastrointestinal prokinetic exploited clinically for the management of motor disorders of the upper gastrointestinal tract, including functional dyspepsia, gastric stasis of various origins and emesis.

Acotiamide Methyl Ether is a metabolite of Acotiamide -- an acetylcholinesterase inhibitor which has been shown to stimulate gastric motility and improve gastric motility dysfunction in rats. Acotiamide Hydrochloride has also been shown to improve meal-related symptoms of functional dyspepsia.

Recanaclotide can be used to treat Gastroparesis, Functional Dyspepsia, and Other Gastrointestinal Disorders.